Patent: 8,697,353
Summary for Patent: 8,697,353
| Title: | Immunization compositions and methods |
| Abstract: | The present invention provides methods and compositions to induce neutralizing antibodies in mammals to serotypes of dengue virus, measles virus, mumps virus, rubella and/or VZV virus. |
| Inventor(s): | Alain Bouckenooghe, Remi Forrat, Denis Crevat |
| Assignee: | Sanofi Pasteur SA |
| Application Number: | US13/019,243 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,697,353
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Llc | PROQUAD | measles, mumps, rubella and varicella virus vaccine live | For Injection | 125108 | September 6, 2005 | ⤷ Start Trial | 2031-02-01 |
| Merck Sharp & Dohme Llc | PROQUAD | measles, mumps, rubella and varicella virus vaccine live | For Injection | 125108 | February 27, 2023 | ⤷ Start Trial | 2031-02-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,697,353
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 080111 | ⤷ Start Trial |
| Australia | 2011212647 | ⤷ Start Trial |
| Brazil | 112012019637 | ⤷ Start Trial |
| China | 102740879 | ⤷ Start Trial |
| European Patent Office | 2353609 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
